Orca1

FDA inspection

Pharmacreams Corporation: FDA inspection ending May 11, 2004

FDA inspection 325631 · Voluntary Action Indicated (VAI) · Medley, FL

Key facts

Inspection ID 325631
Firm Pharmacreams Corporation
FEI number 3004541289
Address 8314 NW South River Dr
City Medley
State FL
ZIP 33166-7422
Fiscal year 2004
Inspection end date May 11, 2004
Classification Voluntary Action Indicated (VAI)
Project area Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation|Drug Quality Assurance|OTC Drug Evaluation
Product type Drugs, Food/Cosmetics

At a glance

  • 10–99 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

Other inspections at this establishment

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections